Search

Your search keyword '"Lirussi Borgnon J"' showing total 7 results
Start Over Author "Lirussi Borgnon J"
7 results on '"Lirussi Borgnon J"'

2. Nutritional status at age 1 year in patients born with esophageal atresia: A population-based, prospective cohort study

Author

Depoortere, S. (Suzanne), Lapillonne, A. (Alexandre), Sfeir, R. (Rony), Bonnard, A. (Arnaud), Gelas, T. (Thomas), Panait, N. (Nicoleta), Rabattu, P-Y. (Pierre-Yves), Guignot, A. (Audrey), Lamireau, T. (Thierry), Irtan, S. (Sabine), Habonimana, E. (Edouard), Breton, A. (Anne), Fouquet, V. (Virginie), Allal, H. (Hossein), Elbaz, F. (Frédéric), Talon, I. (Isabelle), Ranke, A. (Aline), Abely, M. (Michel), Michel, J-L. (Jean-Luc), Lirussi Borgnon, J. (Joséphine), Buisson, P. (Philippe), Schmitt, F. (Françoise), Lardy, H. (Hubert), Petit, T. (Thierry), Chaussy, Y. (Yann), Borderon, C. (Corinne), Levard, G. (Guillaume), Cremillieux, C. (Clara), Tolg, C. (Cécilia), Breaud, J. (Jean), Jaby, O. (Olivier), Grossos, C. (Céline), De Vries, P. (Philine), Arnould, M. (Myriam), Pelatan, C. (Cécile), Geiss, S. (Stephan), Laplace, C. (Christophe), Kyheng, M. (MaÉva), Nicolas, A. (Audrey), Aumar, M. (Madeleine), gottrand, F. (Fréderic), Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biomatériaux et Bioingénierie (BB), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Matériaux et Nanosciences Grand-Est (MNGE), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Reims (CHU Reims), CHU Lille, CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), AP-HP Hôpital universitaire Robert-Debré [Paris], Hospices Civils de Lyon (HCL), CHU Marseille, CHU Grenoble, Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Bordeaux [Bordeaux], CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Pontchaillou [Rennes], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Hôpital Bicêtre, CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), CHU Rouen, Normandie Université (NU), CHU Strasbourg, ESPRI-Biobase [CHRU Nancy] (Unité fonctionnelle de la plateforme d’aide à la recherche clinique), CHR La réunion, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Amiens-Picardie, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), CHU Clermont-Ferrand, Centre hospitalier universitaire de Poitiers (CHU Poitiers), CHU Saint-Etienne, CHU de la Martinique [Fort de France], Centre Hospitalier Universitaire de Nice (CHU Nice), CHU Henri Mondor, CHU Limoges, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Centre Hospitalier Régional d'Orléans (CHRO), Centre Hospitalier Le Mans (CH Le Mans), CH Colmar, CHU Pointe-à-Pitre/Abymes [Guadeloupe], BOURGEAIS, Véronique, Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), CHU Henri Mondor [Créteil], Université de Lille, Inserm, Institute for Translational Research in Inflammation - U 1286 [INFINITE (Ex-Liric)], Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], and Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Subjects
catch-up, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV]Life Sciences [q-bio], growth, prematurity, stunting, syndromic, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, [SDV] Life Sciences [q-bio], undernutrition, small for gestational age, Pediatrics, Perinatology and Child Health, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
Abstract

ObjectiveDespite recent progress in caring for patients born with esophageal atresia (EA), undernutrition and stunting remain common. Our study objective was to assess nutritional status in the first year after birth with EA and to identify factors associated with growth failure.Study designWe conducted a population-based study of all infants born in France with EA between 2010 and 2016. Through the national EA register, we collected prenatal to 1 year follow-up data. We used body mass index and length-for-age ratio Z scores to define patients who were undernourished and stunted, respectively. Factors with P < 0.20 in univariate analyses were retained in a logistic regression model.ResultsAmong 1,154 patients born with EA, body mass index and length-for-age ratio Z scores at 1 year were available for about 61%. Among these, 15.2% were undernourished and 19% were stunted at the age of 1 year. There was no significant catch-up between ages 6 months and 1 year. Patients born preterm (41%), small for gestational age (17%), or with associated abnormalities (55%) were at higher risk of undernutrition and stunting at age 1 year (P < 0.05). Neither EA type nor surgical treatment was associated with growth failure.ConclusionUndernutrition and stunting are common during the first year after birth in patients born with EA. These outcomes are significantly influenced by early factors, regardless of EA type or surgical management. Identifying high-risk patient groups with EA (i.e., those born preterm, small for gestational age, and/or with associated abnormalities) may guide early nutritional support strategies.

Published
2022
Full Text
View/download PDF

3. Mastocytose xanthélasmoïde révélée par une hypertrophie clitoridienne

Author

Caretti, M., Khelef, K., Goubaud, E., Lirussi-Borgnon, J., Ben Signor, C., Bodemer, C., and Bonniaud, B.

Abstract

Les mastocytoses cutanées principalement rencontrées chez l’enfant sont l’urticaire pigmentaire, les mastocytoses papulo-nodulaires – comprenant les formes xanthélasmoïdes – et les mastocytoses cutanées diffuses. Nous rapportons ici le cas d’une patiente atteinte d’une mastocytose xanthélasmoïde révélée par une hypertrophie clitoridienne.

Published
2024
Full Text
View/download PDF

6. Nutritional status at age 1 year in patients born with esophageal atresia: A population-based, prospective cohort study.

Author

Depoortere S, Lapillonne A, Sfeir R, Bonnard A, Gelas T, Panait N, Rabattu PY, Guignot A, Lamireau T, Irtan S, Habonimana E, Breton A, Fouquet V, Allal H, Elbaz F, Talon I, Ranke A, Abely M, Michel JL, Lirussi Borgnon J, Buisson P, Schmitt F, Lardy H, Petit T, Chaussy Y, Borderon C, Levard G, Cremillieux C, Tolg C, Breaud J, Jaby O, Grossos C, De Vries P, Arnould M, Pelatan C, Geiss S, Laplace C, Kyheng M, Nicolas A, Aumar M, and Gottrand F

Abstract

Objective: Despite recent progress in caring for patients born with esophageal atresia (EA), undernutrition and stunting remain common. Our study objective was to assess nutritional status in the first year after birth with EA and to identify factors associated with growth failure., Study Design: We conducted a population-based study of all infants born in France with EA between 2010 and 2016. Through the national EA register, we collected prenatal to 1 year follow-up data. We used body mass index and length-for-age ratio Z scores to define patients who were undernourished and stunted, respectively. Factors with P < 0.20 in univariate analyses were retained in a logistic regression model., Results: Among 1,154 patients born with EA, body mass index and length-for-age ratio Z scores at 1 year were available for about 61%. Among these, 15.2% were undernourished and 19% were stunted at the age of 1 year. There was no significant catch-up between ages 6 months and 1 year. Patients born preterm (41%), small for gestational age (17%), or with associated abnormalities (55%) were at higher risk of undernutrition and stunting at age 1 year ( P < 0.05). Neither EA type nor surgical treatment was associated with growth failure., Conclusion: Undernutrition and stunting are common during the first year after birth in patients born with EA. These outcomes are significantly influenced by early factors, regardless of EA type or surgical management. Identifying high-risk patient groups with EA (i.e., those born preterm, small for gestational age, and/or with associated abnormalities) may guide early nutritional support strategies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential of interest., (Copyright © 2022 Depoortere, Lapillonne, Sfeir, Bonnard, Gelas, Panait, Rabattu, Guignot, Lamireau, Irtan, Habonimana, Breton, Fouquet, Allal, Elbaz, Talon, Ranke, Abely, Michel, Lirussi Borgnon, Buisson, Schmitt, Lardy, Petit, Chaussy, Borderon, Levard, Cremillieux, Tolg, Breaud, Jaby, Grossos, De Vries, Arnould, Pelatan, Geiss, Laplace, Kyheng, Nicolas, Aumar and Gottrand.)

Published
2022
Full Text
View/download PDF

7. Predictors of the Performance of Early Antireflux Surgery in Esophageal Atresia.

Author

François B, Michaud L, Sfeir R, Bonnard A, Rousseau V, Blanc S, Gelas T, Boubnova J, Jacquier C, Irtan S, Breton A, Fouquet V, Guinot A, Lamireau T, Habounimana E, Schneider A, Elbaz F, Ranke A, Poli-Merol ML, Kalfa N, Dupont-Lucas C, Petit T, Michel JL, Buisson P, Lirussi-Borgnon J, Sapin E, Lardy H, Levard G, Parmentier B, Cremillieux C, Lopez M, Podevin G, Schmitt F, Borderon C, Jaby O, Pelatan C, De Vries P, Pouzac-Arnould M, Grosos C, Breaud J, Laplace C, Tolg C, Sika A, Auber F, Labreuche J, Duhamel A, and Gottrand F

Subjects
Anastomosis, Surgical adverse effects, Constriction, Pathologic, Esophageal Atresia classification, Female, France, Gastroesophageal Reflux surgery, Gastrostomy, Humans, Infant, Infant, Low Birth Weight, Infant, Newborn, Male, Multivariate Analysis, Nutritional Status, Registries, Esophageal Atresia surgery, Fundoplication
Abstract

Objective: To identify predictors of and factors associated with the performance of antireflux surgery during the first year of life in children born with esophageal atresia., Study Design: All patients were included in a French registry for esophageal atresia. All 38 multidisciplinary French centers completed questionnaires about perinatal characteristics and one-year outcome for children born with esophageal atresia., Results: Of 835 infants with esophageal atresia born in France from 2010 to 2014, 682 patients, excluding those with long-gap esophageal atresia, were included. Three patients had type I, 669 had type III, and 10 had type IV esophageal atresia. Fifty-three children (7.8%) received fundoplication during the first year of life. The median age at the time of the end-to-end esophageal anastomosis was 1.1 day (range 0-15). Multivariate analysis identified three perioperative factors that predicted the need for early antireflux surgery: anastomotic tension (P = .004), associated malformations (P = .019), and low birth weight (P = .018). Six other factors, measured during the first year of life, were associated with the need for antireflux surgery: gastroesophageal reflux (P < .001), anastomotic stricture (P < .001), gastrostomy (P < .001), acute life-threatening event (P = .002), respiratory complications (P = .045), and poor nutritional status (P < .001)., Conclusions: Gastroesophageal reflux disease, low birth weight, poor nutrition, and surgical anastomosis difficulties predicted the performance of antireflux surgery in the first year of life in infants with esophageal atresia., (Copyright © 2019 Elsevier Inc. All rights reserved.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results